Epsilon M&A Deal Report - Fehling Instruments

Transaction Multiples for the Valuation of Private Companies

Stille > Fehling Instruments

Announced Date : 29 November 2023

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Stille

Target: Fehling Instruments

Target Country: Germany

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1996, Fehling is a family-owned German company, that manufactures medical instrument ...

No EMAT : 114894

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1233

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
01/07/2022	Private group led by Edmond de Rothschild Private Equity	Oncodesign Services (ODS)	France	**
02/11/2021	Private group led by KKR & Co. Inc	Biosynth Beteilingungs	Switzerland	**

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database